EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy

Sixuan Lv iD, Yuhan Wang, Kaixin Jiang, Xinge Guo, Jing Zhang, Fang Zhou, Qiming Li, Yuan Jiang, Changyong Yang, Tieshan Teng iD

Viruses · 14.08.2023 · 15 (8) · 1736

DOI: 10.3390/v15081736 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 14.08.2023. Verfasst von Sixuan Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Health, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Key R&D and Promotion Projects of Henan Province, China Postdoctoral Science Foundation, National Innovation and entrepreneurship training program for college students.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phages possess the ability to selectively eliminate pathogenic bacteria by recognizing bacterial surface receptors. Since their discovery, phages have been recognized for their potent bactericidal properties, making them a promising alternative to antibiotics in the context of rising antibiotic resistance. However, the rapid emergence of phage-resistant strains (generally involving temperature phage) and the limited host range of most phage strains have hindered their antibacterial efficacy, impeding their full potential. In recent years, advancements in genetic engineering and biosynthesis technology have facilitated the precise engineering of phages, thereby unleashing their potential as a novel source of antibacterial agents. In this review, we present a comprehensive overview of the diverse strategies employed for phage genetic engineering, as well as discuss their benefits and drawbacks in terms of bactericidal effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyBacteriophagesAnti-Bacterial AgentsGenetic EngineeringHost Specificity

Stichwörter der Autor:innen

antibioticsbiosynthesis technologygenetic engineeringphage therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • School of Nursing and Health, Henan University, Kaifeng 475004, China.
  • Institute of Biomedical Informatics, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.

ORCID-Profile: Sixuan Lv, Tieshan Teng

Förderung

  • The Key R&D and Promotion Projects of Henan Province
  • China Postdoctoral Science Foundation
  • National Innovation and entrepreneurship training program for college students
  • Natural Science Foundation of Henan Province

Zitieren

APA

Lv, S., Wang, Y., Jiang, K., Guo, X., Zhang, J., Zhou, F., Li, Q., Jiang, Y., Yang, C., & Teng, T. (2023). Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy. Viruses, 15(8), 1736. https://doi.org/10.3390/v15081736

Vancouver

Lv S, Wang Y, Jiang K, Guo X, Zhang J, Zhou F, et al. Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy. Viruses. 2023;15(8):1736. doi:10.3390/v15081736

BibTeX
@article{Lv2023,
  author = {Lv, Sixuan and Wang, Yuhan and Jiang, Kaixin and Guo, Xinge and Zhang, Jing and Zhou, Fang and Li, Qiming and Jiang, Yuan and Yang, Changyong and Teng, Tieshan},
  title = {Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {1736},
  doi = {10.3390/v15081736}
}
Kostenlos starten →